APA (7th ed.) Citation

K, S., AS, S., CP, T., CR, J., EJ, C., A, J., . . . AC, S. (2026). Do hepatic and biliary functional data from gadoxetate-enhanced MRI add value in predicting outcomes in primary sclerosing cholangitis (PSC)? European radiology. https://doi.org/10.1007/s00330-026-12710-5

Chicago Style (17th ed.) Citation

K, Sandrasegaran, et al. "Do Hepatic and Biliary Functional Data from Gadoxetate-enhanced MRI Add Value in Predicting Outcomes in Primary Sclerosing Cholangitis (PSC)?" European Radiology 2026. https://doi.org/10.1007/s00330-026-12710-5.

MLA (9th ed.) Citation

K, Sandrasegaran, et al. "Do Hepatic and Biliary Functional Data from Gadoxetate-enhanced MRI Add Value in Predicting Outcomes in Primary Sclerosing Cholangitis (PSC)?" European Radiology, 2026, https://doi.org/10.1007/s00330-026-12710-5.